Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.44
-0.39 (-2.46%)
At close: Mar 6, 2026, 4:00 PM EST
15.26
-0.18 (-1.15%)
After-hours: Mar 6, 2026, 4:10 PM EST

Pharming Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
-297.2245.32205.62198.87212.17
Revenue Growth (YoY)
-21.15%19.30%3.40%-6.27%11.88%
Cost of Revenue
-35.425.2117.5621.1423.54
Gross Profit
325.68261.8220.1188.06177.73188.64
Selling, General & Admin
211.29189.44179.93131.8296.4275.69
Research & Development
90.5683.1668.9152.5370.3738.52
Other Operating Expenses
304.32274.78272.19198.87169.41116.04
Total Operating Expenses
606.17547.38521.03383.22336.2230.25
Operating Income
-280.49-285.57-300.93-195.16-158.47-41.61
Total Non-Operating Income (Expense)
-0.11-6.63-3.259.52-32.16
Pretax Income
14.65-8.51-12.0114.9923.0844.09
Provision for Income Taxes
13.812.51-1.461.317.086.35
Net Income
0.84-11.03-10.5513.671637.75
Net Income to Common
0.84-11.03-10.5513.671637.75
Net Income Growth
----14.52%-57.62%-7.05%
Shares Outstanding (Basic)
686766656464
Shares Outstanding (Diluted)
687973717068
Shares Change (YoY)
3.43%8.26%2.59%0.85%2.70%1.37%
EPS (Basic)
0.01-0.18-0.160.210.250.58
EPS (Diluted)
0.01-0.18-0.160.190.230.55
EPS Growth
----17.39%-58.18%-8.33%
Free Cash Flow
52.72-2.58-18.7421.0827.178.97
Free Cash Flow Growth
----22.21%-65.68%9.73%
Free Cash Flow Per Share
--0.03-0.260.300.391.16
Gross Margin
-88.09%89.72%91.46%89.37%88.91%
Operating Margin
--96.09%-122.67%-94.91%-79.68%-19.61%
Profit Margin
--3.71%-4.30%6.65%8.04%17.79%
FCF Margin
--0.87%-7.64%10.25%13.63%37.22%
EBITDA
-264.78-269.5-285-181.98-138.86-33.3
EBITDA Margin
--90.68%-116.18%-88.50%-69.82%-15.69%
EBIT
-280.49-285.57-300.93-195.16-158.47-41.61
EBIT Margin
--96.09%-122.67%-94.91%-79.68%-19.61%
Effective Tax Rate
94.30%-29.53%12.19%8.76%30.69%14.40%
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q